BANK OF MONTREAL /CAN/ - TRANSITION THERAPEUTICS INC ownership

TRANSITION THERAPEUTICS INC's ticker is TTHI and the CUSIP is 893716209. A total of 2 filers reported holding TRANSITION THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TRANSITION THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$1,0000.0%4620.0%0.00%
Q1 2016$1,0000.0%4620.0%0.00%
Q4 2015$1,0000.0%4620.0%0.00%
Q3 2015$1,0000.0%4620.0%0.00%
Q2 2015$1,000
-66.7%
4620.0%0.00%
Q1 2015$3,0000.0%4620.0%0.00%
Q4 2014$3,000
-40.0%
462
-34.6%
0.00%
Q3 2014$5,0000.0%7060.0%0.00%
Q2 2014$5,000
+400.0%
706
+536.0%
0.00%
Q1 2014$1,0000.0%1110.0%0.00%
Q4 2013$1,0000.0%111
-66.7%
0.00%
Q3 2013$1,0000.0%3330.0%0.00%
Q2 2013$1,0003330.00%
Other shareholders
TRANSITION THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 4,863,914$10,214,0001.24%
Birchview Capital, LP 145,746$306,0000.16%
DAFNA Capital Management LLC 59,222$124,0000.10%
HOLLENCREST CAPITAL MANAGEMENT 162,196$341,0000.05%
VESTOR CAPITAL, LLC 42,600$89,0000.03%
Plante Moran Financial Advisors, LLC 17,034$36,0000.03%
SABBY MANAGEMENT, LLC 302,837$636,0000.02%
SPHERA FUNDS MANAGEMENT LTD. 70,273$148,0000.01%
FineMark National Bank & Trust 22,807$48,0000.01%
Alyeska Investment Group, L.P. 394,858$830,0000.01%
View complete list of TRANSITION THERAPEUTICS INC shareholders